In the last 5 years
We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers as we’ve advanced their development.
Your partner in developing cell, gene and other advanced therapies
Access multi-disciplinary, multi-modality experience to support your unique studies.
Get a patient-centric approach to optimize the development of your product.
Rely on our team to navigate complex logistics and implement practical solutions.
Our top therapeutic areas for cell and gene therapies include:
In this 61-minute, on-demand presentation, our speakers discussed recent progress in several therapeutic areas, provided updates in kidney disease and shared operational considerations when planning cell and gene therapy clinical development programs as well as conducting pediatric gene editing studies.
Not only do we know how to work with these complex entities and recognize real or potential impacts on patient well-being, but we also understand the science behind how they work. We understand how these treatments are developed and manufactured, and how these complex characteristics impact the conduct of a clinical trial including:
The complexity of these therapies can involve numerous operational challenges defined by the asset in development and reflected in the trial footprint. We offer best practices, solutions and technologies and operational flexibility to optimize the conduct of your clinical trial, including, but not limited to:
To ensure your team keeps up with complex and rapidly evolving technologies, we provide comprehensive custom training of all team members. Our Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT) and Oncology members provide targeted, study-specific training, as well as a formal Cell and Gene Therapy Training curriculum.